Keith J. Kendall, CEO and President at Aquestive Therapeutics, Inc. (AQST), sold 100,000 shares at $5.11 ($511K) on 2020-06-04, disclosed to the SEC on 2020-06-05.
Open-market sale of $511k AQST by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.11 | 50,000 | $256K | 50.0% |
| 2 | $5.11 | 50,000 | $256K | 50.0% |
| Total | $5.11 avg | 100,000 | $511K | 100% |
| Filing → |
| AQST | BUY | 2018-11-26 | $80K | — | Filing → |